» Articles » PMID: 15448087

Investigation of the Role of B-cells in Type 1 Diabetes in the NOD Mouse

Overview
Journal Diabetes
Specialty Endocrinology
Date 2004 Sep 28
PMID 15448087
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

B-cells are important in the development of type 1 diabetes, but their role is not completely defined. Although B-cells produce autoantibodies, these are not thought to be pathogenic; however, their antigen-presenting function is postulated to be critical. To examine the relative importance of these functions of B-cells, we have generated nonobese diabetic (NOD) B-cell-deficient mice that express a transgene encoding a mutant heavy chain immunoglobulin transgene on the cell surface but cannot secrete immunoglobulins (mIgs). This allowed us to dissect the importance of the relative roles of antigen presentation, dissociated from antibody production. We found that the expression of the mIg transgene increased insulitis and the incidence of diabetes compared with transgene-negative NOD B-cell-deficient mice, indicating that the ability to produce antibodies is not necessary for B-cells to have some effect on the development of diabetes. However, diabetes was not restored to the level seen in normal NOD mice. This may relate to reduced ability to activate an islet-specific T-cell repertoire, presumably due to the reduced islet-specific B-cell repertoire. Our results implicate a specific antigen-presenting function for B-cells.

Citing Articles

The role of B cells in the pathogenesis of type 1 diabetes.

Wang Y, Li R, Huang Y, Chen H, Nie H, Liu L Front Immunol. 2025; 15():1450366.

PMID: 39776900 PMC: 11703732. DOI: 10.3389/fimmu.2024.1450366.


Mechanisms underlying the development of type 1 diabetes in ART-treated people living with HIV: an enigmatic puzzle.

Zaongo S, Zongo A, Chen Y Front Immunol. 2024; 15:1470308.

PMID: 39257582 PMC: 11383789. DOI: 10.3389/fimmu.2024.1470308.


Islet-antigen reactive B cells display a unique phenotype and BCR repertoire in autoantibody positive and recent-onset type 1 diabetes patients.

Nicholas C, Tensun F, Evans S, Toole K, Broncucia H, Hesselberth J bioRxiv. 2024; .

PMID: 38979376 PMC: 11230262. DOI: 10.1101/2024.06.20.599914.


The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner.

Stock A, Gonzalez Paredes P, de Almeida L, Kosanke S, Chetlur S, Budde H Front Immunol. 2024; 15:1349601.

PMID: 38487540 PMC: 10937421. DOI: 10.3389/fimmu.2024.1349601.


Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SCs) through the Galectin-9-Dependent Mechanism.

Hu W, Song X, Yu H, Fan S, Shi A, Sun J Int J Mol Sci. 2024; 25(3).

PMID: 38339108 PMC: 10855911. DOI: 10.3390/ijms25031830.